All Reports

China TAVR market is expected to reach US$1,669.14 million in 2026, growing at a CAGR of 55.50%, for the duration spanning 2022-2026. While, the TMV market in China is forecasted to reach US$741.24 million in 2026, rising at a CAGR of 147.16%, for the time period of 2022-2026. Factors such as growing prevalence of aortic stenosis, rise in approval of new TAVR products, rise in geriatric populat ..

The global radiation therapy market is expected to reach US$12.44 billion in 2026, witnessing growth at a CAGR of 6.75%, over the period 2022-2026. Factors such as surging incidence of cancer cases, rising healthcare expenditure, upsurge in economic growth, growing aging population and expanding urbanization are expected to drive the market. The growth of the market would be challenged by sever ..

The global plasma derived therapy market is anticipated to reach US$50.70 billion in 2026, growing at a CAGR of 7.20% during the period spanning 2022-2026. The growth in the market has been driven by factors like rising geriatric population, increasing prevalence of genetic disorders, government initiatives, rising demand for albumin, escalating use of plasma proteins in pharmaceuticals, increa ..

The China biological reagent market is forecasted to reach US$6.39 billion in 2026, experiencing growth at a CAGR of 14.87% during the period spanning from 2022 to 2026. Growth in the China biological reagent market was supported by factors such as increasing research in the field of life sciences, technological innovations, rising number of genome projects, rising incidence of genetic disorder ..

The US health expenditure is forecasted to reach US$5.75 trillion in 2026, experiencing growth at a CAGR of 5.57% during the period spanning from 2022 to 2026. The national health expenditure by source of funds can be segmented as follows: Managed care, out of pocket, Investments and Others. In 2021, the dominant share was held by managed care segment. This was being followed by out of pocket, ..

The global RNAi therapeutics market is expected to record a value of US$1.15 billion in 2026, progressing at a CAGR of 10.19%, over the period 2022-2026. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress in collaborations and associate ..

The global interventional pulmonology market is forecasted to reach US$4.68 billion in 2026, rising at a CAGR of 5.84%, for the time period of 2022-2026. Factors such as growing incidence of lung cancer, rising CO2 emission, expansion of medical device industry, surging COPD mortality rate, increasing elderly population and increasing public awareness would drive the growth of the market. Howev ..

The global point of care diagnostics market is anticipated to reach US$37.93 billion in 2026, growing at a CAGR of 6.59% during the period spanning 2022-2026. The growth in the market has been driven by factors like rising global healthcare expenditure, rising geriatric population, escalating stress issues, increasing prevalence of chronic and infectious diseases, rising utilization of novel im ..

The U.S. medical diagnostics market is anticipated to reach US$40.10 billion in 2026, witnessing growth at a CAGR of 4.63%, over the period 2022-2026. The factors such as increasing geriatric population, growing burden of chronic diseases, escalating penetration of electronic health record (EHR) systems, hike in healthcare expenditure and expanding urbanization would drive the growth of the mar ..

European medical diagnostics market is expected to reach US$98.43 billion in 2026, growing at a CAGR of 5.67%, for the time period of 2022-2026. Factors such as rise in number of new cancer cases, expansion of medical device industry, growth in geriatric population, accelerating demand for In-Vitro Diagnostic (IVD) and rapid urbanization would drive the growth of the market. However the market ..